Sunday, September 27, 2020

Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Sharing information with shareholders, Sun Pharmaceutical Industries
Managing Director Dilip Shanghvi said the company's strategy of
developing the specialty business as an additional growth engine has
started delivering results, with a gradual ramp up in specialty
revenues.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bullish-on-specialty-biz-looks-to-expand-the-segment-to-new-geographies/articleshow/78344062.cms

No comments:

Post a Comment